ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Pain Medicine

Top Pain Medicine Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SAMYADEV DATTA MD

Pain Medicine

3,988

$623K

267
144 are 65+

78%
patients receiving schedule two controlled substances

Avg: 50%

11%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 28%

$156
Average prescription price

Avg: $145

ROBERT SILVERMAN M.D

Pain Medicine

2,683

$290K

290
229 are 65+

51%
patients receiving schedule two controlled substances

Avg: 50%

27%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$108
Average prescription price

Avg: $145

VANNETTE PERKINS MD

Pain Medicine

2,362

$269K

179
75 are 65+

63%
patients receiving schedule two controlled substances

Avg: 50%

31%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$114
Average prescription price

Avg: $145

MORRIS ANTEBI MD

Pain Medicine

2,362

$210K

587
144 are 65+

60%
patients receiving schedule two controlled substances

Avg: 50%

29%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $145

ISAIAH FLORENCE MD

Pain Medicine

1,928

$231K

186
93 are 65+

58%
patients receiving schedule two controlled substances

Avg: 50%

30%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 28%

$120
Average prescription price

Avg: $145

JOHN SECOY MD

Pain Medicine

1,709

$275K

131
94 are 65+

43%
patients receiving schedule two controlled substances

Avg: 50%

36%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$161
Average prescription price

Avg: $145

MANJULA SINGH M.D.

Pain Medicine

1,688

$156K

368
172 are 65+

80%
patients receiving schedule two controlled substances

Avg: 50%

14%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$93
Average prescription price

Avg: $145

FELIX ROQUE MD

Pain Medicine

1,539

$784K

235
167 are 65+

28%
patients receiving schedule two controlled substances

Avg: 50%

0%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 28%

$509
Average prescription price

Avg: $145

ROBERT CHAPDELAINE M.D.

Pain Medicine

1,406

$153K

292
149 are 65+

67%
patients receiving schedule two controlled substances

Avg: 50%

23%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$109
Average prescription price

Avg: $145

BINOD SINHA M.D.

Pain Medicine

1,404

$471K

248
80 are 65+

66%
patients receiving schedule two controlled substances

Avg: 50%

13%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$336
Average prescription price

Avg: $145

MILIND PATHARKAR M.D.

Pain Medicine

1,228

$132K

266
86 are 65+

74%
patients receiving schedule two controlled substances

Avg: 50%

18%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$108
Average prescription price

Avg: $145

SCOTT METZGER M.D.

Pain Medicine

1,184

$110K

231
182 are 65+

13%
patients receiving schedule two controlled substances

Avg: 50%

10%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 28%

$93
Average prescription price

Avg: $145

KENNETH PARK DO

Pain Medicine

1,004

$174K

123
87 are 65+

47%
patients receiving schedule two controlled substances

Avg: 50%

21%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 28%

$173
Average prescription price

Avg: $145

SEAN LI M.D.

Pain Medicine

916

$67.9K

286
234 are 65+

21%
patients receiving schedule two controlled substances

Avg: 50%

19%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 28%

$74
Average prescription price

Avg: $145

JEFFREY PETERSOHN M.D.

Pain Medicine

871

$70.9K

156
103 are 65+

51%
patients receiving schedule two controlled substances

Avg: 50%

22%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$81
Average prescription price

Avg: $145

GIOVANNI RAMUNDO M.D.

Pain Medicine

809

$109K

101
80 are 65+

39%
patients receiving schedule two controlled substances

Avg: 50%

23%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 28%

$134
Average prescription price

Avg: $145

TOMI PRVULOVIC MD

Pain Medicine

795

$163K

78
36 are 65+

68%
patients receiving schedule two controlled substances

Avg: 50%

0%
patients receiving schedule three controlled substances

Avg: 14%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 28%

$205
Average prescription price

Avg: $145

TODD KOPPEL MD

Pain Medicine

790

$165K

73
29 are 65+

68%
patients receiving schedule two controlled substances

Avg: 50%

18%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$209
Average prescription price

Avg: $145

GAREN GAJIAN MD

Pain Medicine

754

$98K

90
28 are 65+

73%
patients receiving schedule two controlled substances

Avg: 50%

12%
patients receiving schedule three controlled substances

Avg: 14%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$130
Average prescription price

Avg: $145

RAKESH GUPTA MD

Pain Medicine

734

$56K

148
100 are 65+

39%
patients receiving schedule two controlled substances

Avg: 50%

19%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$76
Average prescription price

Avg: $145

NATHAN HOLTZBERG M.D

Pain Medicine

686

$143K

75
49 are 65+

51%
patients receiving schedule two controlled substances

Avg: 50%

25%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$209
Average prescription price

Avg: $145

MICHAEL SABIA M.D.

Pain Medicine

614

$79.5K

138
64 are 65+

56%
patients receiving schedule two controlled substances

Avg: 50%

10%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 28%

$129
Average prescription price

Avg: $145

PETER STAATS M.D.

Pain Medicine

583

$61.6K

194
136 are 65+

31%
patients receiving schedule two controlled substances

Avg: 50%

28%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 28%

$106
Average prescription price

Avg: $145

EDNAN SHEIKH MD

Pain Medicine

579

$29.6K

102
53 are 65+

31%
patients receiving schedule two controlled substances

Avg: 50%

23%
patients receiving schedule three controlled substances

Avg: 14%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $145

WAYNE FLEISCHHACKER DO

Pain Medicine

572

$31.3K

109
64 are 65+

41%
patients receiving schedule two controlled substances

Avg: 50%

23%
patients receiving schedule three controlled substances

Avg: 14%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 28%

$55
Average prescription price

Avg: $145

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank